56.6 F
Los Angeles
Sunday, Dec 8, 2024

Maximus Raises $10M in Series A

Maximus Health Inc., a Santa Monica consumer telemedicine company, has raised $10 million in its Series A funding round.

The company said the money will be used to expand access, grow brand awareness, and invest in product development.

The round was led by Keith Rabois of the San Francisco-based Founders Fund. Among the individual angel investors were Brian Lee, co-founder of LegalZoom.com, Shoe Dazzle and The Honest Co., all of Los Angeles.

The company had previously raised $5 million in a seed funding round led in May of last year by 10X Capital and nine other investors.

Maximus provides at-home lab testing and doctor-prescribed protocols to optimize men’s health and hormone function. The company serves thousands of members. Dr. Cam Sepah, chief executive of Maximus, said he was excited to welcome the investors to the company saying in a statement that they “allowed us to innovate and grow faster than any telemedicine company in this space.”

Before Maximus came along, men’s health startups sold ineffective supplements that didn’t work or unsafe medications that worsened infertility or sexual dysfunction, Sepah claimed.
“Our advisory board of the top medical school professors and doctors helped us develop cutting-edge scientific protocols, with proven safety and efficacy to enhance performance,” he said in a statement. “We’ve helped thousands of men become the best versions of themselves, along with the peace of mind that our protocols benefit their overall health and well-being.”

Through its proprietary King protocol, Maximus customers can use prescription medication and health coaching to optimize testosterone levels. This is done with pills that are easy to prescribe and take, testosterone replacement therapy, injectables or controlled substances. At-home lab tests are part of the program, which costs $199 a month for the doctor’s visit, coaching and medication.

The company’s newest product is the Lover protocol, which uses a combination of prescription medications that enhances blood flow and libido to improve both sexual performance and enjoyment. The Lover protocol costs $149 a month and includes doctor consultations, medication and coaching. The memberships do not require a contract.

Other investors in the round included 10X Capital; Unshackled Ventures, in Palo Alto; 8VC, OneVC and Shrug Capital, all in San Francisco; Electric Ant, in Los Angeles; What If Ventures, in Frisco, Texas; Correlation Ventures, in San Diego; Chamaeleon VC, in San Mateo; and Gaingels, in Vermont.

Featured Articles

Related Articles

MARK R. MADLER Author